| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38af8d02ee2f2f7115c0082519f2417b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
| filingDate |
2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37dae31b41fc595431915ac96a94c86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bc080c5ab620685ea6be5f51d0f2201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b5ed99184a8c054dc018d66b2d39498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcaba17bdb4b402cba038a1aef1f9e56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b64b2c0b228c8e9edba7c1a5a757e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c0cc23c4a9d86c83edba0aaa93f61d |
| publicationDate |
2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020172452-A |
| titleOfInvention |
Treatments for Parkinson's disease or Lewy body disease and screening methods thereof |
| abstract |
PROBLEM TO BE SOLVED: To provide a disease-modifying therapy for Parkinson's disease (PD) and Lewy bodies (LBD) by a mechanism for suppressing the interneuronal transmission phenomenon of fibrotic α-SYN. A therapeutic agent for Parkinson's disease or Lewy body disease, which contains a fibrotic α-SYN receptor protein that specifically binds to fibrotic α-SYN. [Selection diagram] None |
| priorityDate |
2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |